Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.49 - $0.61 $5,457 - $6,794
11,138 Added 0.49%
2,294,948 $1.4 Million
Q3 2022

Nov 14, 2022

SELL
$0.0 - $0.93 $0 - $42,617
-45,825 Reduced 1.97%
2,283,810 $970,000
Q2 2022

Aug 12, 2022

SELL
$0.38 - $0.89 $718,824 - $1.68 Million
-1,891,643 Reduced 44.81%
2,329,635 $1.89 Million
Q1 2022

May 13, 2022

SELL
$0.58 - $0.86 $168,480 - $249,815
-290,483 Reduced 6.44%
4,221,278 $2.54 Million
Q4 2021

Feb 11, 2022

BUY
$0.73 - $1.28 $1.38 Million - $2.42 Million
1,890,771 Added 72.14%
4,511,761 $3.68 Million
Q3 2021

Nov 12, 2021

SELL
$0.77 - $4.91 $176,769 - $1.13 Million
-229,571 Reduced 8.05%
2,620,990 $2.08 Million
Q2 2021

Aug 13, 2021

BUY
$2.18 - $4.66 $3.37 Million - $7.21 Million
1,546,900 Added 118.66%
2,850,561 $13.2 Million
Q1 2021

May 12, 2021

BUY
$1.3 - $3.24 $627,268 - $1.56 Million
482,514 Added 58.76%
1,303,661 $3.39 Million
Q4 2020

Feb 12, 2021

BUY
$1.01 - $1.77 $40,864 - $71,614
40,460 Added 5.18%
821,147 $1.11 Million
Q3 2020

Nov 13, 2020

BUY
$0.67 - $1.4 $16,666 - $34,825
24,875 Added 3.29%
780,687 $1.09 Million
Q2 2020

Aug 13, 2020

BUY
$0.52 - $0.87 $9,871 - $16,515
18,983 Added 2.58%
755,812 $544,000
Q1 2020

May 14, 2020

BUY
$0.39 - $1.03 $5,344 - $14,114
13,703 Added 1.89%
736,829 $413,000
Q4 2019

Feb 13, 2020

BUY
$0.89 - $1.5 $33,002 - $55,621
37,081 Added 5.41%
723,126 $752,000
Q3 2019

Nov 12, 2019

BUY
$1.04 - $1.51 $180,934 - $262,702
173,975 Added 33.97%
686,045 $802,000
Q2 2019

Aug 14, 2019

BUY
$0.95 - $2.46 $63,601 - $164,694
66,949 Added 15.04%
512,070 $768,000
Q3 2018

Nov 13, 2018

BUY
$1.54 - $2.38 $67,026 - $103,587
43,524 Added 10.84%
445,121 $957,000
Q2 2018

Aug 14, 2018

BUY
$1.04 - $3.29 $417,660 - $1.32 Million
401,597 New
401,597 $783,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Sesen Bio, Inc.


  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.